Fludarabine
Contents
Description
Fludarabine is a purine analog antimetabolite used in conditioning regimens for hematopoietic stem cell transplantation. It is utilized in the treatment of severe combined immunodeficiency and other primary immunodeficiency disorders requiring transplantation. The drug provides immunosuppression and myeloablation necessary for successful engraftment.
Indications & Therapeutic Use
Conditioning regimen for hematopoietic stem cell transplantation, chronic lymphocytic leukemia, severe combined immunodeficiency
Global Availability (6 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Fludarabine — GNH India
90 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Fludarabine |
| Brands | 1 brand available |
| Active Ingredient | Fludarabine phosphate |
| Drug Class | Conditioning regimen for hematopoietic stem cell transplantation |
| Manufacturer | Genzyme |
| Dosage Forms | IV infusion, 25mg/mL; Oral tablet, 10mg |
| Medical Code | L01BB05 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 10 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00002639 |
| Countries | 6 countries |